First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer (Q47575129)
Jump to navigation
Jump to search
scientific article published on 22 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer |
scientific article published on 22 October 2011 |
Statements
1 reference
First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer (English)
1 reference
Vincent Chung
1 reference
Elisabeth I Heath
1 reference
William R Schelman
1 reference
Brendan M Johnson
1 reference
Lyndon C Kirby
1 reference
Kerlin M Lynch
1 reference
Jeffrey D Botbyl
1 reference
Thomas A Lampkin
1 reference
Kyle D Holen
1 reference
22 October 2011
1 reference
69
1 reference
3
1 reference
733-741
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference